252 related articles for article (PubMed ID: 3118038)
1. Phenotypic changes in monocytes and alveolar macrophages in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC).
Roy G; Rojo N; Leyva-Cobián F
J Clin Lab Immunol; 1987 Jul; 23(3):135-41. PubMed ID: 3118038
[TBL] [Abstract][Full Text] [Related]
2. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
Salazar-Gonzalez JF; Moody DJ; Giorgi JV; Martinez-Maza O; Mitsuyasu RT; Fahey JL
J Immunol; 1985 Sep; 135(3):1778-85. PubMed ID: 2991373
[TBL] [Abstract][Full Text] [Related]
3. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.
Hance AJ; Douches S; Winchester RJ; Ferrans VJ; Crystal RG
J Immunol; 1985 Jan; 134(1):284-92. PubMed ID: 3964815
[TBL] [Abstract][Full Text] [Related]
4. All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma.
Gonwa TA; Frost JP; Karr RW
J Immunol; 1986 Jul; 137(2):519-24. PubMed ID: 3088102
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1 and interleukin 2 production in the acquired immune deficiency syndrome (AIDS) and AIDS-related complex.
Gupta S; Vayuvegula B; Ruhling M; Thornton M
J Clin Lab Immunol; 1987 Mar; 22(3):113-6. PubMed ID: 3112400
[TBL] [Abstract][Full Text] [Related]
6. Expression of HLA class II antigens and secretion of interleukin-1 by monocytes and macrophages from adults and neonates.
Glover DM; Brownstein D; Burchett S; Larsen A; Wilson CB
Immunology; 1987 Jun; 61(2):195-201. PubMed ID: 3496273
[TBL] [Abstract][Full Text] [Related]
7. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
8. A phase I/II trial of recombinant interleukin-2 in AIDS/ARC: alterations of phenotypes of peripheral blood mononuclear cells.
Flad HD; Ernst M; Kern P
Lymphokine Res; 1986; 5 Suppl 1():S171-6. PubMed ID: 3491258
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic and additive effects of IL-4 and interferon-gamma on human monocytes and macrophages: effects on Fc receptors, HLA-D antigens, and superoxide production.
Becker S; Daniel EG
Cell Immunol; 1990 Sep; 129(2):351-62. PubMed ID: 2166625
[TBL] [Abstract][Full Text] [Related]
10. Monocyte phenotype and function in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders.
Haas JG; Riethmüller G; Ziegler-Heitbrock HW
Scand J Immunol; 1987 Oct; 26(4):371-9. PubMed ID: 3685887
[TBL] [Abstract][Full Text] [Related]
11. The accessory cell function of human alveolar macrophages in specific T cell proliferation.
Toews GB; Vial WC; Dunn MM; Guzzetta P; Nunez G; Stastny P; Lipscomb MF
J Immunol; 1984 Jan; 132(1):181-6. PubMed ID: 6228577
[TBL] [Abstract][Full Text] [Related]
12. Differential abilities of human peripheral blood monocytes quantitatively or qualitatively differing in HLA-DR and HLA-DS expression to support B cell activation in liquid and semisolid cultures.
Whisler RL; Newhouse YG; Lachman LB
J Immunol; 1985 Jul; 135(1):172-9. PubMed ID: 3873488
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of human class II antigens on monocytes from patients with acquired immune deficiency syndrome. Increased expression with interferon-gamma.
Heagy W; Kelley VE; Strom TB; Mayer K; Shapiro HM; Mandel R; Finberg R
J Clin Invest; 1984 Dec; 74(6):2089-96. PubMed ID: 6439741
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood dendritic cells in persons with AIDS and AIDS related complex: loss of high intensity class II antigen expression and function.
Eales LJ; Farrant J; Helbert M; Pinching AJ
Clin Exp Immunol; 1988 Mar; 71(3):423-7. PubMed ID: 2968202
[TBL] [Abstract][Full Text] [Related]
15. Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.
Venet A; Hance AJ; Saltini C; Robinson BW; Crystal RG
J Clin Invest; 1985 Jan; 75(1):293-301. PubMed ID: 3871200
[TBL] [Abstract][Full Text] [Related]
16. IL-2 production and response in vitro by the leukocytes of patients with acquired immune deficiency syndrome.
Reuben JM; Hersh EM; Murray JL; Munn CG; Mehta SR; Mansell PW
Lymphokine Res; 1985; 4(2):103-16. PubMed ID: 2987624
[TBL] [Abstract][Full Text] [Related]
17. Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma.
Liversidge JM; Sewell HF; Forrester JV
Clin Exp Immunol; 1988 Sep; 73(3):489-94. PubMed ID: 3145163
[TBL] [Abstract][Full Text] [Related]
18. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain.
Hansson GK; Jonasson L; Holm J; Claesson-Welsh L
Clin Exp Immunol; 1986 May; 64(2):261-8. PubMed ID: 3527502
[TBL] [Abstract][Full Text] [Related]
19. The density of HLA-DR antigen expression on alveolar macrophages is increased in pulmonary sarcoidosis.
Campbell DA; du Bois RM; Butcher RG; Poulter LW
Clin Exp Immunol; 1986 Jul; 65(1):165-71. PubMed ID: 3791697
[TBL] [Abstract][Full Text] [Related]
20. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
